Dark Forest Capital Management LP Dynavax Technologies Corp Transaction History

Dark Forest Capital Management LP

  • $634 Million
  • Q4 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
SELL
$10.27 - $13.29 $6,316 - $8,173
-615 Reduced 94.18%
38 $0
Q3 2022

Nov 14, 2022
BUY
$9.93 - $17.44 $4,577 - $8,039
461 Added 240.1%
653 $7,000
Q2 2022

Aug 15, 2022
SELL
$7.45 - $12.83 $663,549 - $1.14 Million
-89,067 Reduced 99.78%
192 $2,000
Q1 2022

May 13, 2022
BUY
$9.75 - $14.44 $870,275 - $1.29 Million
89,259 New
89,259 $968,000

Others Institutions Holding DVAX

# of Institutions
288
Shares Held
131M
Call Options Held
507K
Put Options Held
374K
View Full List

About DYNAVAX TECHNOLOGIES CORP

DVAX Quotes by TradingView
  • Ticker DVAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 126,474,000
  • Market Cap $1.74B
  • Description
  • Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...
More about DVAX
Track This Portfolio

Track Dark Forest Capital Management LP Portfolio

Follow Dark Forest Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Dark Forest Capital Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email